arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

INSULET CORP

PODD
$156.11 ▼ -8.82 (-5.35%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
77
Health
Good
Bullish
auto_awesome

Analytical Summary

INSULET CORP shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $11.0B
Dividend Yield —
Revenue Growth 30.7% ↗
Op. Margin 17.5% ↗
ROIC 22.8% ↘
FCF / Share $5.37 ↗
Trailing P/E 44.5x
Price / Book 7.3x
FCF Yield 3.4%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.71B
↑ +30.7% —
Net Income Profit after all expenses
$247.10M
↓ -40.9% —
Operating Margin Operating profit as % of sales
17.5%
↑ +17.3% 71th
FCF / Share Free cash flow per share
$5.37
↑ +23.2% —
Long-Term Debt Long-term obligations
$1.40B
↑ +10.0% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
68
Returns ↑
82
Financial Health ↑
82
Cash Quality
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters